Evidence map›Paper›PMID 31075315›Full record

ArticleNitric oxide : biology and chemistry2019

Exogenous l-ARGININE does not stimulate production OF NO or cGMP within the rat corporal smooth muscle cells in culture.

Monica G Ferrini, Andrea Abraham, Sabine Nguyen, Robert Luna, Manuel Flores, Jorge N Artaza, Leslie Graciano, Jacob Rajfer

Open access · greenAbstract read
In one paragraph

Article in Nitric oxide : biology and chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Effect of DCardiology discovery · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Monica G FerriniDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: monicaferrini@cdrewu.edu.
Andrea AbrahamDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Sabine NguyenDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Robert LunaDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Manuel FloresDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Jorge N ArtazaDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Leslie GracianoDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Jacob RajferDepartment of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Charles R. Drew University of Medicine and Science · USUniversity of California, Los Angeles · US

Funding

Workshop for Junior Biostatisticians in Health ResearchU54MD007598 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI Ali Andalibi, Jose A Torres-Ruiz · 2012 to 2026
$60.0M
Nitric Oxide/cGMP Modulation of Corporal Fibrosis Caused by NeuropraxiaSC1NS064611 · NINDS · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI FERRINI, MONICA GABRIELA · 2008 to 2012
$1.4M
NIMHD NIH HHS U54 MD007598NINDS NIH HHS SC1 NS064611
6 · The paper itself

Abstract

BACKGROUND AND

aimNitric oxide (NO) is the intracellular chemical responsible for initiating a penile erection. Despite conflicting clinical data, it continues to be publicized and promoted that orally administered l-arginine, the putative substrate for NO, enhances the erectile response presumably by stimulating NO production by the corporal tissues resulting in an increase in cGMP production. To shed light on this issue, an in vitro study was conducted to explore the effect of direct exogenous administration of l-arginine as well as its precursor and metabolite, l-citrulline, on the NO-cGMP pathway within the cavernosal smooth muscle (CSM) cell. MATERIALS AND

methodsCSM cells obtained from 8 to 10 week old Sprague-Dawley rats were grown in Dulbecco media with 20% fetal calf serum and then incubated with or without l-arginine (L-ARG) or l-citrulline (L-CIT) in a time course and dose-response manner. Sildenafil (0.4 mM), IBMX (1 mM), l-NAME (3 μM), ODQ (5 μM) and Deta Nonoate (10 μM) were used as either inhibitors or stimulators of the NO-cGMP pathway. mRNA and protein were extracted and used for the determination of the phosphodiesterase 5 (PDE5). PDE5 activity was determined by luminometry. cGMP content was determined by ELISA. Nitrite formation, an indicator of NO production, was measured in the cell culture media by a colorimetric assay. The cationic (CAT-1) and neutral (SNAT-1) amino acid transporters for L-ARG and L-CIT, respectively, were determined by Western blot.

resultsWhen compared to untreated CSM cells, incubation with 0.25-4.0 mM of L-ARG or 0.3-4.8 mM of L-CIT anywhere between 3 and 24 h did not result in any additional nitrite or cGMP production. The addition of l-NAME, IBMX or ODQ to these L-ARG and L-CIT treated cells did not alter these results. L-CIT but not L-ARG increased PDE5 mRNA and protein content as well as the activity of the PDE5 enzyme. Both CAT-1 and SNAT-1 were expressed in the CSM cells.

conclusionsThis in vitro study demonstrates that exogenous administration of L-ARG or L-CIT failed to stimulate production of either NO or cGMP by the corporal CSM cells. A re-evaluation of the presumptive role of the exogenous administration of L-ARG in improving the synthesis of NO at least at the level of the CSM cells appears warranted.

Indexed as

AnimalsArginineCells, CulturedCitrullineCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 5MaleMuscle, SmoothMyocytes, Smooth MuscleNG-Nitroarginine Methyl EsterNitric OxideNitritesPenisPhosphodiesterase 5 InhibitorsRats, Sprague-DawleyArginineCitrullineCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 5NG-Nitroarginine Methyl EsterNitric OxideNitritesPhosphodiesterase 5 InhibitorscGMPL-argininel-citrullinePDE 5Rat cavernosal smooth muscle cells

Identifiers

PMID31075315
PMCPMC6786268
OpenAlexW2944451145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.